Work

Author response: Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice

Year: 2024

Type: peer-review

Abstract: Pharmacological activation of farnesoid X (FXR) receptor by hammerhead-type agonists induces a novel enhancer RNA, termed Fincor, contributing to the amelioration of nonalcoholic steatohepatitis in mice.

DOI: 10.7554/elife.91438.3.sa3

Authors: Jinjing Chen, Ruoyu Wang, Feng Xiong, Hao Sun, Byron Kemper, Wenbo Li, Jongsook Kemper

Institutions: University of Illinois Urbana-Champaign, The University of Texas Health Science Center at Houston

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Funders: University of Minnesota, University of Oklahoma, National Institutes of Health

Awards: G3823532681, G6543560800

OpenAlex ID: W4394798646

Cites:

Cited by: 1

Related to: 10